| 1541/2267 | US=60 / Cab/Pesc Goldstein DP, Clark J, Gullane PJ, Dawson LA, Siu LL, Irish JC. Carcinoma of the hypopharynx. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 44-69. ISBN 978-1-58890-508-6. CARCINOMA DA HIPOFARINGE; CANCER DE HIPOFARINGE; ESTUDO DE CASO |
| 1542/2267 | US=60 / Cab/Pesc El-Deiry MW, Trask DK, Hoffman HT, Dornfeld KJ. Carcinoma of the larynx. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 70-89. ISBN 978-1-58890-508-6. |
| 1543/2267 | US=60 / Cab/Pesc Genden EM, Brett EM. Carcinoma of the thyroid. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 90-104. ISBN 978-1-58890-508-6. |
| 1544/2267 | US=60 / Cab/Pesc Wax MK, Gross ND, Andersen PE. Carcinoma of the salivary glands. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 105-17. ISBN 978-1-58890-508-6. CARCINOMA DAS GLANDULAS SALIVARES; CANCER DAS GLANDULAS SALIVARES; ESTUDO DE CASO |
| 1545/2267 | US=60 / Cab/Pesc Chaboki H, Wanna GB, Westreich R, Kao J, Packer SH, Lawson W. Carcinoma of the nasal cavity and paranasal sinus. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 118-36. ISBN 978-1-58890-508-6. CARCINOMA DA CAVIDADE NASAL; CARCINOMA DOS SEIOS PARANASAIS; CANCER DA CAVIDADE NASAL; CANCER DOS SEIOS PARANASAIS; ESTUDO DE CASO |
| 1546/2267 | US=60 / Cab/Pesc Wei WI, Sham JST. Carcinoma of the nasopharynx. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 137-51. ISBN 978-1-58890-508-6. CARCINOMA DA NASOFARINGE; CANCER DA NASOFARINGE; ESTUDO DE CASO |
| 1547/2267 | US=60 / Cab/Pesc Moore BA, Rosenthal D, Kies MS, Weber RS. Carcinoma of the skin of the head, face, and neck. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 152-79. ISBN 978-1-58890-508-6. CARCINOMA DA PELE DA CABECA; CARCINOMA DA PELE DA FACE; CARCINOMA DA PELE DO PESCOCO; ESTUDO DE CASO |
| 1548/2267 | US=60 / Cab/Pesc Genden EM, Kao J, Packer SH, Jacobson AS. Carcinoma of unknown primary site. In: Genden EM, Varvares MA. Head and neck cancer: an evidence-based team approach. New York: Thieme, 2008. p. 180-97. ISBN 978-1-58890-508-6. |
| 1549/2267 | US=62 / Câncer Weiss LM. Epithelial and nevomelanocytic lesions of lymph nodes. In: ___. Lymph nodes. New York: Cambridge University Press, 2008. p. 82-8. (Illustrated Surgical Pathology) ISBN 978-0-521-87161-7. LESOES EPITELIAIS; NEVOMELANOCITICO DE LINFONODOS; NEVO MELANOCITICO LINFONODAL; CARCINOMA |
| 1550/2267 | US=44 / Gastro Molena D, Herbella F, Peters JH. Esophageal adenocarcinoma: surgical management of esophageal carcinoma. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 51-65. ISBN 978-1-4051-2783-7. CANCER DE ESOFAGO; CARCINOMA ESOFAGICO. TRATAMENTO CIRURGICO |
| 1551/2267 | US=44 / Gastro Wolfsen HC. Esophageal adenocarcinoma: ablation, novel agents, and endoscopic therapy for esophageal dysplasia and carcinoma. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 87-97. ISBN 978-1-4051-2783-7. ADENOCARCINOMA ESOFAGICO; ABLACAO; TRATAMENTO ENDOSCOPICO; DISPLASIA DO ESOFAGO; CARCINOMA DE ESOFAGO; ADENOCARCINOMA; ESOFAGO DE BARRETT |
| 1552/2267 | US=65 / Biol/Mol Jost M, Vosseler S, Blacher S, Fusenig NE, Mueller MM, Noël A. The surface transplantation model to study the tumor-host interface. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 327-42. ISBN 978-0-387-69056-8. MODELO DE TRANSPLANTE DE SUPERFICIE; TUMOR-HOSPEDEIRO; CARCINOMA DE CELULAS ESCAMOSAS DA PELE; INVASAO DE CELULA TUMORAL; INIBIDORES DE PROTEASES; COMPARTIMENTO DE TUMOR; CAMUNDONGOS DEFICIENTES; MMP; TUMOR ESTROMAL |
| 1553/2267 | US=65 / Biol/Mol Lah TT, Obermajer N, Alonso MBD, Kos J. Cysteine cathepsins and cystatins as cancer biomarkers. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 587-625. ISBN 978-0-387-69056-8. CATEPSINAS; CISTEINA; CISTATINAS; BIOMARCADORES DE CANCER; PEPTIDASES; PESQUISA CLINICA; CARCINOMA DE MAMA; CARCINOMA DE PROSTATA; CARCINOMA DO COLO DO UTERO; CARCINOMA DE OVARIO; CARCINOMA DE PULMAO; CARCINOMA DE COLON; CARCINOMA DE CABECA E PESCOCO; CARCINOMA DA BEXIGA; CARCINOMA DE PANCREAS; CANCER DE FIGADO; CARCINOMA HEPATOCELULAR; MELANOMA; MENINGIOMA; GLIOMA |
| 1554/2267 | US=67 / Biol/Mol Wadler S. Molecular targeting in upper gastrointestinal malignancies. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 117-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. NEOPLASIAS GASTROINTESTINAIS SUPERIORES; SEGMENTACAO MOLECULAR; CARCINOMA HEPATOCELULAR; CANCER DE PANCREAS; CANCER DE ESTOMAGO; TERAPIA-ALVO |
| 1555/2267 | US=67 / Biol/Mol Schwartz JD, Llovet JM. Molecular targeting in hepatocellular carcinoma. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 165-210. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CARCINOMA HEPATOCELULAR; ALVO MOLECULAR; TERAPEUTICA ANTI-ANGIOGENESE; FATORES DE CRESCIMENTO |
| 1556/2267 | US=67 / Biol/Mol Hahn O, Stadler W. Renal cell carcinoma: renal cell cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 241-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CARCINOMA DE CELULAS RENAIS; CANCER DE CELULAS RENAIS; TERAPIA MOLECULAR |
| 1557/2267 | US=67 / Biol/Mol Koon HB, Atkins MB. Cytokine-based therapy for cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 471-507. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER. TERAPIA; CITOQUINA; INTERFERON; INTERLEUCINA; IMUNOTERAPIA; RESISTENCIA; LEUCEMIA DE CELULAS PILOSAS; LEUCEMIA MIELOIDE CRONICA; LINFOMA NAO-HODGKIN; MELANOMA; CARCINOMA DE CELULAS RENAIS; SARCOMA DE KAPOSI |
| 1558/2267 | US=67 / Imagem Dziadziuszko R, Hirsch FR, Bunn Junior PA. Advances in lung cancer treatment. In: Mulshine JL, Baer TM. Quantitative imaging tools for lung cancer drug assessment. New Jersey: John Wiley & Sons, 2008. p. 17-37. ISBN 978-0-470-11880-1. CANCER DE PULMAO; TERAPIA; CARCINOMA DE PULMAO DE NAO-PEQUENAS CELULAS; TRATAMENTO PALIATIVO; CARCINOMA DE PULMAO DE PEQUENAS CELULAS |
| 1559/2267 | US=69 / Câncer Jonasch E, Tannir N. Targeted therapy in renal cell carcinoma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 305-16. ISBN 978-1-60327-423-4. TERAPIA-ALVO; CARCINOMA DE CELULAS RENAIS; MUTACAO BVS; ANTIVASCULAR TERAPIA; TERAPEUTICA DE COMBINACAO; TERAPIA SEQUENCIAL |
| 1560/2267 | US=7 / Tórax Moreira JS, Geyer GR, Felicetti JC, Porto NS. Carcinoma brônquico. In: Tarantino AB. Doenças pulmonares. 6ª ed. Rio de Janeiro: Guanabara Koogan, 2008. p. 591-607. ISBN 85-2771333-7. |